Webinars & Whitepapers →
March 18, 2020 · San Diego
April 29, 2020 · Boston
May 5, 2020 · New York
TetraPhase Pharmaceuticals, spun out of Harvard in 2006 with $25 million to develop synthetic antibiotics, reached an important corporate milestone last week: the company had its first paintball outing. Though still... Read more »
Sponsored · Whitepaper
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders
© 2007-2020, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.